A current comprehensive role of immune-checkpoint inhibitors in resectable non-small cell lung cancer: A narrative review.
Safa Can EfilSebnem YucelFurkan CeylanHilal Karakaşİrfan KarahanSema Nur ÖzsanHakan KoskuŞebnem YamanMuhammed Bülent AkıncıDidem Şener DedeBülent YalçınMehmet Ali Nahit ŞendurPublished in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2024)
Despite the promising outcomes from these trials there remain several unanswered questions. In this review, we will assess clinical trials involving adjuvant, neoadjuvant, and perioperative ICIs, aiming to address the unresolved questions related to these therapeutic approaches.